UK NICE issues first guidance under new medtech evaluation programme
This article was originally published in RAJ Devices
The UK health technology assessment body, NICE, has published the first draft guidance under its medical devices evaluation programme, which aims to accelerate the adoption of new technologies in the National Health Service1,2.
You may also be interested in...
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?